Ubs Group Ag Vascular Biogenics Ltd. Transaction History

Ubs Group Ag

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$0.21 - $0.32 $11 - $16	53 New	53 $0
Q4 2022 Feb 08, 2023	SELL	$0.11 - $0.16 $6,835 - $9,942	-62,139 Reduced 95.71%	2,784 $0
Q3 2022 Nov 10, 2022	BUY	$0.15 - $2.1 $9,738 - $136,338	64,923 New	64,923 $10,000
Q2 2022 Aug 10, 2022	SELL	$1.22 - $1.95 $519 - $830	-426 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.15 - $1.97 $2,196 - $3,762	-1,910 Reduced 81.76%	426 $1,000
Q4 2021 Feb 14, 2022	BUY	$1.92 - $2.53 $3,809 - $5,019	1,984 Added 563.64%	2,336 $5,000
Q3 2021 Nov 15, 2021	SELL	$1.94 - $2.55 $13,188 - $17,334	-6,798 Reduced 95.08%	352 $1,000
Q2 2021 Aug 13, 2021	BUY	$1.69 - $2.67 $12,083 - $19,090	7,150 New	7,150 $17,000
Q3 2020 Nov 12, 2020	SELL	$1.11 - $1.4 $800 - $1,009	-721 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$1.12 - $1.63 $4,344 - $6,322	-3,879 Reduced 84.33%	721 $1,000
Q1 2020 May 01, 2020	BUY	$0.96 - $1.57 $3,364 - $5,502	3,505 Added 320.09%	4,600 $6,000
Q4 2019 Feb 14, 2020	SELL	$1.1 - $1.32 $1,459 - $1,751	-1,327 Reduced 54.79%	1,095 $1,000
Q3 2019 Nov 14, 2019	BUY	$1.11 - $1.42 $2,688 - $3,439	2,422 New	2,422 $3,000
Q1 2019 May 14, 2019	SELL	$0.94 - $1.75 $7,034 - $13,095	-7,483 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.6 - $1.72 $1,866 - $5,350	3,111 Added 71.16%	7,483 $7,000
Q3 2018 Nov 14, 2018	BUY	$1.55 - $2.17 $6,776 - $9,487	4,372 New	4,372 $7,000
Q1 2018 May 15, 2018	SELL	$2.27 - $8.5 $2,270 - $8,500	-1,000 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	1,000	1,000 $4,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.